Catherine E O'Riordan is a notable inventor based in Jamaica Plain, MA (US). She has made significant contributions to the field of biotechnology, particularly in the purification of viruses for therapeutic applications. With a total of 3 patents, her work has had a profound impact on gene therapy and related medical fields.

Latest Patents

One of her latest patents focuses on the purification of adenovirus and AAV. This invention relates to the purification of large-scale quantities of active (infectious) adenovirus and AAV, especially for use in therapeutic applications. The invention provides improved methods for contacting such viruses with suitable chromatographic materials, minimizing or eliminating any damage to the virus, particularly to its surface components. The result is the ability to rapidly and efficiently purify commercial-level quantities of active (infectious) virus suitable for use in therapeutic applications, such as gene transfer and therapy procedures.

Career Highlights

Catherine E O'Riordan is currently associated with Genzyme Corporation, where she continues to advance her research and innovations. Her work has been instrumental in developing methods that enhance the safety and efficacy of viral therapies.

Collaborations

Some of her notable coworkers include Alan E Smith and Amy L (Ericson) Helgerson. Their collaborative efforts contribute to the ongoing advancements in the field of biotechnology.

Conclusion

Catherine E O'Riordan's contributions to the purification of viruses for therapeutic applications highlight her innovative spirit and dedication to improving medical treatments. Her work continues to pave the way for advancements in gene therapy and related fields.